| Year |
Citation |
Score |
| 2023 |
Vismara M, Benatti B, Fineberg NA, Hollander E, Van Ameringen M, Menchon JM, Zohar J, Dell'Osso B. Lessons from a multicenter, international, large sample size analysis of patients with obsessive-compulsive disorders: an overview of the ICOCS Snapshot studies. Cns Spectrums. 1-9. PMID 37694338 DOI: 10.1017/S1092852923002432 |
0.359 |
|
| 2023 |
Taoulost S, Rasgon N, Ferretti CJ, Hollander E. The role of ketogenic therapy in developmental disorders. Journal of Psychiatric Research. 161: 307-309. PMID 36989905 DOI: 10.1016/j.jpsychires.2023.03.025 |
0.31 |
|
| 2022 |
Piccoli E, Hollander E. Editor's Commentary: Problematic Use of the internet in Autism Spectrum Disorder: A canary in the coal mine? Journal of Psychiatric Research. 155: 260-262. PMID 36116405 DOI: 10.1016/j.jpsychires.2022.09.002 |
0.346 |
|
| 2022 |
Fineberg NA, Menchón JM, Hall N, Dell'Osso B, Brand M, Potenza MN, Chamberlain SR, Cirnigliaro G, Lochner C, Billieux J, Demetrovics Z, Rumpf HJ, Müller A, Castro-Calvo J, Hollander E, et al. Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet. Comprehensive Psychiatry. 118: 152346. PMID 36029549 DOI: 10.1016/j.comppsych.2022.152346 |
0.604 |
|
| 2022 |
Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Hollander E, Kasper S, Möller HJ, Eriksson E, Fineberg NA, Hättenschwiler J, Kaiya H, Karavaeva T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-17. PMID 35900217 DOI: 10.1080/15622975.2022.2086296 |
0.419 |
|
| 2022 |
Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-39. PMID 35900161 DOI: 10.1080/15622975.2022.2086295 |
0.482 |
|
| 2022 |
Hollander E, Jacob S, Jou R, McNamara N, Sikich L, Tobe R, Smith J, Sanders K, Squassante L, Murtagh L, Gleissl T, Wandel C, Veenstra-VanderWeele J. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 35793101 DOI: 10.1001/jamapsychiatry.2022.1717 |
0.31 |
|
| 2022 |
Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, King BH, McCracken JT, Scahill L, Sikich L, Pickles A. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 32: 233-241. PMID 35501967 DOI: 10.1089/cap.2021.0137 |
0.329 |
|
| 2022 |
Benatti B, Girone N, Celebre L, Vismara M, Hollander E, Fineberg NA, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, van Ameringen M, Lochner C, Karamustafalioglu O, Hranov L, et al. The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network. Comprehensive Psychiatry. 116: 152315. PMID 35483201 DOI: 10.1016/j.comppsych.2022.152315 |
0.664 |
|
| 2022 |
Taylor BP, Liu J, Mowrey W, Eule E, Bolognani F, Hollander E. The Montefiore-Einstein Rigidity Scale-Revised (MERS-R): Development, administration, reliability, and validity in child and adult Autism Spectrum Disorder (ASD). Journal of Psychiatric Research. 147: 142-147. PMID 35032947 DOI: 10.1016/j.jpsychires.2021.12.055 |
0.312 |
|
| 2021 |
Benatti B, Dell'Osso B, Shen H, Filippou-Frye M, Varias A, Sanchez C, Jo B, Hollander E, Fineberg NA, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Van Ameringen M, et al. Prevalence and correlates of current suicide risk in an international sample of OCD adults: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacology. Journal of Psychiatric Research. 140: 357-363. PMID 34139458 DOI: 10.1016/j.jpsychires.2021.05.054 |
0.626 |
|
| 2020 |
Castle D, Beilharz F, Phillips KA, Brakoulias V, Drummond LM, Hollander E, Ioannidis K, Pallanti S, Chamberlain SR, Rossell SL, Veale D, Wilhelm S, Van Ameringen M, Dell'Osso B, Menchon JM, et al. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. International Clinical Psychopharmacology. PMID 33230025 DOI: 10.1097/YIC.0000000000000342 |
0.405 |
|
| 2020 |
Benatti B, Celebre L, Girone N, Priori A, Bruno A, Viganò C, Hollander E, Dell'Osso B. Clinical characteristics and comorbidity associated with female gender in obsessive-compulsive disorder. Journal of Psychiatric Research. 131: 209-214. PMID 32998082 DOI: 10.1016/j.jpsychires.2020.09.019 |
0.348 |
|
| 2020 |
Fineberg NA, Hollander E, Pallanti S, Walitza S, Grünblatt E, Dell'Osso BM, Albert U, Geller DA, Brakoulias V, Janardhan Reddy YC, Arumugham SS, Shavitt RG, Drummond L, Grancini B, De Carlo V, et al. Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders. International Clinical Psychopharmacology. PMID 32433254 DOI: 10.1097/Yic.0000000000000314 |
0.557 |
|
| 2020 |
Fineberg NA, Van Ameringen M, Drummond L, Hollander E, Stein DJ, Geller D, Walitza S, Pallanti S, Pellegrini L, Zohar J, Rodriguez CI, Menchon JM, Morgado P, Mpavaenda D, Fontenelle LF, et al. How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. Comprehensive Psychiatry. 100: 152174. PMID 32388123 DOI: 10.1016/J.Comppsych.2020.152174 |
0.695 |
|
| 2020 |
Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross-Sectional Analysis. Journal of Autism and Developmental Disorders. PMID 32279223 DOI: 10.1007/S10803-020-04493-5 |
0.373 |
|
| 2019 |
Burchi E, Makris N, Lee MR, Pallanti S, Hollander E. Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation. Frontiers in Behavioral Neuroscience. 13: 70. PMID 31139059 DOI: 10.3389/Fnbeh.2019.00070 |
0.483 |
|
| 2019 |
Dell'Osso B, Vismara M, Benatti B, Cirnigliaro G, Grancini B, Fineberg NA, Van Ameringen M, Hollander E, Stein DJ, Menchon JM, Rodriguez CI, Nicolini H, Lanzagorta N, Pallanti S, Grassi G, et al. Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-7. PMID 31131775 DOI: 10.1017/S1092852919001068 |
0.72 |
|
| 2019 |
Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. The American Journal of Psychiatry. appiajp201918101180. PMID 31109199 DOI: 10.1176/Appi.Ajp.2019.18101180 |
0.373 |
|
| 2019 |
Dong N, Nezgovorova V, Hong K, Hollander E. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments. Expert Opinion On Pharmacotherapy. 1-9. PMID 31038370 DOI: 10.1080/14656566.2019.1610385 |
0.436 |
|
| 2019 |
Fineberg NA, Dell'Osso B, Albert U, Maina G, Geller D, Carmi L, Sireau N, Walitza S, Grassi G, Pallanti S, Hollander E, Brakoulias V, Menchon JM, Marazziti D, Ioannidis K, et al. Early intervention for obsessive compulsive disorder: An expert consensus statement. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30773387 DOI: 10.1016/J.Euroneuro.2019.02.002 |
0.55 |
|
| 2019 |
Hollander E, Jean Ferretti C. Assessment and Treatment of Autism Spectrum Disorder Psychiatric News. 54. DOI: 10.1176/appi.pn.2019.1a21 |
0.386 |
|
| 2018 |
Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Grünblatt E, Brand M, Billieux J, Carmi L, King DL, Grant JE, Yücel M, Dell'Osso B, Rumpf HJ, Hall N, ... Hollander E, et al. Manifesto for a European research network into Problematic Usage of the Internet. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 1232-1246. PMID 30509450 DOI: 10.1016/J.Euroneuro.2018.08.004 |
0.454 |
|
| 2018 |
Del Valle Rubido M, McCracken JT, Hollander E, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. In Search of Biomarkers for Autism Spectrum Disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 30324656 DOI: 10.1002/Aur.2026 |
0.379 |
|
| 2018 |
Hollander E, Uzunova G, Taylor BP, Noone R, Racine E, Doernberg E, Freeman K, Ferretti CJ. Randomized Crossover Feasibility Trial of Helminthic Trichuris Suis Ova vs. Placebo for Repetitive Behaviors in Adult Autism Spectrum Disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-25. PMID 30230399 DOI: 10.1080/15622975.2018.1523561 |
0.45 |
|
| 2018 |
Burchi E, Hollander E, Pallanti S. From Treatment Response to Recovery - a Realistic Goal in OCD. The International Journal of Neuropsychopharmacology. PMID 30184141 DOI: 10.1093/Ijnp/Pyy079 |
0.444 |
|
| 2018 |
Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Pharmacological Treatment Of Body Dysmorphic Disorder. Current Neuropharmacology. PMID 29701157 DOI: 10.2174/1570159X16666180426153940 |
0.525 |
|
| 2018 |
Hong K, Nezgovorova V, Hollander E. New perspectives in the treatment of body dysmorphic disorder. F1000research. 7: 361. PMID 29636904 DOI: 10.12688/F1000Research.13700.1 |
0.452 |
|
| 2018 |
Benatti B, Dell’Osso B, Rodriguez CI, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Ameringen MV, Lochner C, et al. Exploring Sociodemographic And Clinical Correlates Of Older Adults With Obsessive-Compulsive Disorder: A Report From The International College Of Obsessive-Compulsive Disorders (Icocs) European Neuropsychopharmacology. 28: 765-766. DOI: 10.1016/J.Euroneuro.2017.10.007 |
0.649 |
|
| 2018 |
Rahman A, Freedman R, Hollander E. S59. Alpha-7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Galantamine in Autism Spectrum Disorder Biological Psychiatry. 83: S369-S370. DOI: 10.1016/J.Biopsych.2018.02.950 |
0.344 |
|
| 2017 |
Mitelman SA, Buchsbaum MS, Young DS, Haznedar MM, Hollander E, Shihabuddin L, Hazlett EA, Bralet MC. Increased white matter metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging and Behavior. PMID 29168086 DOI: 10.1007/S11682-017-9785-9 |
0.336 |
|
| 2017 |
Kabasakalian A, Ferretti CJ, Hollander E. Oxytocin and Prader-Willi Syndrome. Current Topics in Behavioral Neurosciences. PMID 28956320 DOI: 10.1007/7854_2017_28 |
0.391 |
|
| 2017 |
Dell'Osso B, Benatti B, Rodriguez CI, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Van Ameringen M, Lochner C, et al. Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Disorders (ICOCS). European Psychiatry : the Journal of the Association of European Psychiatrists. 45: 36-40. PMID 28728093 DOI: 10.1016/J.Eurpsy.2017.06.008 |
0.696 |
|
| 2017 |
Chiarello F, Spitoni S, Hollander E, Matucci Cerinic M, Pallanti S. An expert opinion on PANDAS/PANS: highlights and controversies. International Journal of Psychiatry in Clinical Practice. 21: 91-98. PMID 28498087 DOI: 10.1080/13651501.2017.1285941 |
0.462 |
|
| 2017 |
Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum MS. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging and Behavior. PMID 28425060 DOI: 10.1007/S11682-017-9721-Z |
0.307 |
|
| 2017 |
Vasudeva SB, Hollander E. Body Dysmorphic Disorder in Patients With Autism Spectrum Disorder: A Reflection of Increased Local Processing and Self-Focus. The American Journal of Psychiatry. 174: 313-316. PMID 28366095 DOI: 10.1176/Appi.Ajp.2016.16050559 |
0.473 |
|
| 2017 |
Dell'Osso B, Benatti B, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, van Ameringen M, Lochner C, Karamustafalioglu O, et al. Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-8. PMID 28300008 DOI: 10.1017/S1092852917000177 |
0.669 |
|
| 2017 |
Hollander E, Uzunova G. Are there new advances in the pharmacotherapy of autism spectrum disorders? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 101-102. PMID 28127936 DOI: 10.1002/Wps.20398 |
0.478 |
|
| 2017 |
Dell'Osso B, Benatti B, Hollander E, Altamura AC. Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder. International Journal of Psychiatry in Clinical Practice. 21: 131-136. PMID 27809644 DOI: 10.1080/13651501.2016.1249891 |
0.443 |
|
| 2017 |
Dell׳Osso B, Benatti B, Nicolini H, Lanzagorta N, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Ameringen MV, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, et al. Childhood, Adolescent And Adult Age At Onset And Related Clinical Correlates In Obsessive-Compulsive Disorder: A Report From The International College Of Obsessive-Compulsive Disorders (Icocs) European Neuropsychopharmacology. 27: 610-611. DOI: 10.1016/J.Euroneuro.2016.07.013 |
0.646 |
|
| 2017 |
Hollander E, Pallanti S, McElroy S, Fineberg N. 44. Experimental Therapeutics, Mechanism of Action, and Striatal Gradients in Compulsive and Impulsive Disorders Biological Psychiatry. 81: S19. DOI: 10.1016/J.Biopsych.2017.02.055 |
0.445 |
|
| 2016 |
Umbricht D, Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Scahill L, Noeldeke J, Boak L, Khwaja O, Squassante L, Grundschober C, Kletzl H, Fontoura P. A Single Dose, Randomized, Controlled Proof-of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27711048 DOI: 10.1038/Npp.2016.232 |
0.386 |
|
| 2016 |
DellʼOsso B, Benatti B, Altamura AC, Hollander E. Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients With Obsessive Compulsive Disorder. Journal of Clinical Psychopharmacology. 36: 725-726. PMID 27631577 DOI: 10.1097/Jcp.0000000000000572 |
0.454 |
|
| 2016 |
Hollander E, Hong K. Relapse Prevention and the Need for Ongoing Pharmacological Treatment in Body Dysmorphic Disorder. The American Journal of Psychiatry. 173: 857-9. PMID 27581691 DOI: 10.1176/Appi.Ajp.2016.16050624 |
0.455 |
|
| 2016 |
Dell'Osso B, Benatti B, Hollander E, Fineberg N, Stein DJ, Lochner C, Nicolini H, Lanzagorta N, Palazzo C, Altamura AC, Marazziti D, Pallanti S, Van Ameringen M, Karamustafalioglu O, Drummond LM, et al. Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). International Journal of Psychiatry in Clinical Practice. 1-8. PMID 27433835 DOI: 10.1080/13651501.2016.1207087 |
0.685 |
|
| 2016 |
Doernberg E, Hollander E. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. Cns Spectrums. 21: 295-9. PMID 27364515 DOI: 10.1017/S1092852916000262 |
0.484 |
|
| 2016 |
Menchón JM, van Ameringen M, Dell'Osso B, Denys D, Figee M, Grant JE, Hollander E, Marazziti D, Nicolini H, Pallanti S, Ruck C, Shavitt R, Stein DJ, Andersson E, Bipeta R, et al. Standards of care for obsessive-compulsive disorder centres. International Journal of Psychiatry in Clinical Practice. 20: 204-208. PMID 27359333 DOI: 10.1080/13651501.2016.1197275 |
0.691 |
|
| 2016 |
Hollander E, Doernberg E, Shavitt R, Waterman RJ, Soreni N, Veltman DJ, Sahakian BJ, Fineberg NA. The cost and impact of compulsivity: A research perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 26: 800-9. PMID 27235690 DOI: 10.1016/J.Euroneuro.2016.02.006 |
0.502 |
|
| 2016 |
Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. Journal of Psychopharmacology (Oxford, England). PMID 26843373 DOI: 10.1177/0269881116628427 |
0.39 |
|
| 2016 |
Uzunova G, Pallanti S, Hollander E. Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 17: 174-86. PMID 26469219 DOI: 10.3109/15622975.2015.1085597 |
0.432 |
|
| 2016 |
Del Valle Rubido M, Hollander E, McCracken J, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders European Neuropsychopharmacology. 26: S193. DOI: 10.1016/S0924-977X(16)31031-8 |
0.405 |
|
| 2016 |
Hollander E, Ferretti CJ, Taylor BP, Noone R, Kirsch J, Racine E. TRICHURIS SUIS OVA (TSO) AS AN IMMUNE-INFLAMMATORY TREATMENT FOR REPETITIVE BEHAVIORS IN ASD European Neuropsychopharmacology. 26: 891. DOI: 10.1016/J.Euroneuro.2015.06.023 |
0.388 |
|
| 2016 |
Ferretti CJ, Taylor BP, Noone R, Racine E, Kirsch J, Hollander E. HYPERTHERMIA AND THE IMPROVEMENT OF ASD SYMPTOMS European Neuropsychopharmacology. 26: 890-891. DOI: 10.1016/J.Euroneuro.2015.06.022 |
0.335 |
|
| 2016 |
Hollander E, Taylor BP, Racine E, Ferretti CJ, Noone R. IMPULSIVITY AND COMPULSIVITY: TRANSLATIONAL APPROACHES TO COMPULSIVITY IN AUTISM SPECTRUM DISORDERS European Neuropsychopharmacology. 26: 889-890. DOI: 10.1016/J.Euroneuro.2015.06.021 |
0.331 |
|
| 2015 |
Grant JE, Fineberg N, van Ameringen M, Cath D, Visser H, Carmi L, Pallanti S, Hollander E, van Balkom AJ. New treatment models for compulsive disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621260 DOI: 10.1016/J.Euroneuro.2015.11.008 |
0.519 |
|
| 2015 |
Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, et al. Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-5. PMID 26349811 DOI: 10.1017/S1092852915000565 |
0.663 |
|
| 2015 |
Simberlund J, Ferretti CJ, Hollander E. Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-8. PMID 26230216 DOI: 10.3109/15622975.2015.1067372 |
0.406 |
|
| 2015 |
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals. Psychological Science. 26: 1177-86. PMID 26122122 DOI: 10.1177/0956797615580279 |
0.717 |
|
| 2015 |
Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 64-73. PMID 25655160 DOI: 10.1002/Wps.20199 |
0.332 |
|
| 2015 |
Seibell PJ, Hamblin RJ, Hollander E. Obsessive-Compulsive Disorder: Overview and Standard Treatment Strategies Psychiatric Annals. 45: 297-302. DOI: 10.3928/00485713-20150602-04 |
0.495 |
|
| 2015 |
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals Psychological Science. 26: 1177-1186. DOI: 10.1177/0956797615580279 |
0.687 |
|
| 2015 |
Del Valle Rubido M, Umbricht D, Shic F, McCracken J, Scahill L, Khwaja O, Squassante L, Boak L, Bolognani F, Fontoura P, Wall C, Jou R, Loomis R, Lyons M, Gavaletz A, ... ... Hollander E, et al. P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder European Neuropsychopharmacology. 25: S646-S647. DOI: 10.1016/S0924-977X(15)30917-2 |
0.348 |
|
| 2014 |
Seibell PJ, Hollander E. Management of obsessive-compulsive disorder. F1000prime Reports. 6: 68. PMID 25165567 DOI: 10.12703/P6-68 |
0.492 |
|
| 2014 |
Chaim CH, Nazar BP, Hollander E, Lessa JL. Pathological gambling treated with lithium: the role of assessing temperament. Addictive Behaviors. 39: 1911-3. PMID 25163751 DOI: 10.1016/J.Addbeh.2014.05.016 |
0.463 |
|
| 2014 |
Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Comprehensive Psychiatry. 55: 1513-9. PMID 25011690 DOI: 10.1016/J.Comppsych.2014.05.020 |
0.725 |
|
| 2014 |
Hollander E. Obsessive-compulsive disorder and spectrum across the life span. International Journal of Psychiatry in Clinical Practice. 9: 79-86. PMID 24930787 DOI: 10.1080/13651500510018347 |
0.529 |
|
| 2014 |
Hollander E. Anxiety and OC spectrum disorders over life cycle. International Journal of Psychiatry in Clinical Practice. 5-10. PMID 24926866 DOI: 10.1080/13651500701388468 |
0.532 |
|
| 2014 |
Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMS in resistant mixed states: an exploratory study. Journal of Affective Disorders. 157: 66-71. PMID 24581830 DOI: 10.1016/J.Jad.2013.12.024 |
0.358 |
|
| 2014 |
Uzunova G, Hollander E, Shepherd J. The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. Current Neuropharmacology. 12: 71-98. PMID 24533017 DOI: 10.2174/1570159X113116660046 |
0.395 |
|
| 2014 |
Van Ameringen M, Simpson W, Patterson B, Dell'Osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, et al. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Journal of Psychopharmacology (Oxford, England). 28: 596-602. PMID 24429223 DOI: 10.1177/0269881113517955 |
0.674 |
|
| 2014 |
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 375-80. PMID 24406025 DOI: 10.1016/J.Euroneuro.2013.12.003 |
0.393 |
|
| 2014 |
Hollander E. Compulsivity and impulsivity-personal reflections: why now and why here? Cns Spectrums. 19: 6-7. PMID 24284261 DOI: 10.1017/S1092852913000886 |
0.34 |
|
| 2014 |
Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process Cns Spectrums. 19: 62-68. PMID 24229702 DOI: 10.1017/S1092852913000722 |
0.371 |
|
| 2014 |
Pallanti S, Hollander E. Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity. Cns Spectrums. 19: 50-61. PMID 24176028 DOI: 10.1017/S1092852913000618 |
0.466 |
|
| 2014 |
Benatti B, Dell'Osso B, Arici C, Hollander E, Altamura AC. Characterizing impulsivity profile in patients with obsessive-compulsive disorder. International Journal of Psychiatry in Clinical Practice. 18: 156-60. PMID 24151922 DOI: 10.3109/13651501.2013.855792 |
0.456 |
|
| 2014 |
Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. Journal of Autism and Developmental Disorders. 44: 948-57. PMID 24077782 DOI: 10.1007/S10803-013-1952-2 |
0.391 |
|
| 2014 |
Hollander E, Ferretti C, Taylor B, Noone R, Racine E. P.7.d.006 Trichuris Suis Ova (TSO) as an immune-inflammatory treatment for repetitive behaviors in autism spectrum disorders (ASD) European Neuropsychopharmacology. 24: S723. DOI: 10.1016/S0924-977X(14)71165-4 |
0.414 |
|
| 2014 |
Racine E, Kahn T, Hollander E. Compulsive Buying Disorder Behavioral Addictions: Criteria, Evidence, and Treatment. 285-315. DOI: 10.1016/B978-0-12-407724-9.00012-4 |
0.42 |
|
| 2013 |
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. Jama Pediatrics. 167: 1045-52. PMID 24061784 DOI: 10.1001/Jamapediatrics.2013.2698 |
0.347 |
|
| 2013 |
Dell'Osso B, Benatti B, Buoli M, Altamura AC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Nicolini H, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, et al. The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 865-71. PMID 23791074 DOI: 10.1016/J.Euroneuro.2013.05.004 |
0.654 |
|
| 2013 |
Doyle-Thomas KA, Duerden EG, Taylor MJ, Lerch JP, Soorya LV, Wang AT, Fan J, Hollander E, Anagnostou E. Effects of age and symptomatology on cortical thickness in autism spectrum disorders. Research in Autism Spectrum Disorders. 7: 141-150. PMID 23678367 DOI: 10.1016/J.Rasd.2012.08.004 |
0.358 |
|
| 2013 |
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/S10803-013-1775-1 |
0.382 |
|
| 2013 |
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 121-8. PMID 21486110 DOI: 10.3109/15622975.2011.560964 |
0.387 |
|
| 2012 |
Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3: 16. PMID 23216716 DOI: 10.1186/2040-2392-3-16 |
0.68 |
|
| 2012 |
Fan J, Bernardi S, Van Dam NT, Anagnostou E, Gu X, Martin L, Park Y, Liu X, Kolevzon A, Soorya L, Grodberg D, Hollander E, Hof PR. Functional deficits of the attentional networks in autism. Brain and Behavior. 2: 647-60. PMID 23139910 DOI: 10.1002/Brb3.90 |
0.328 |
|
| 2012 |
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice. 16: 77-84. PMID 22540422 DOI: 10.3109/13651501.2012.667114 |
0.477 |
|
| 2012 |
Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. The American Journal of Psychiatry. 169: 292-9. PMID 22193531 DOI: 10.1176/Appi.Ajp.2011.10050764 |
0.396 |
|
| 2012 |
Marazziti D, Rossi L, Baroni S, Consoli G, Hollander E, Catena-Dell'Osso M. Novel treatment options of binge eating disorder. Current Medicinal Chemistry. 18: 5159-64. PMID 22050761 DOI: 10.2174/092986711797636045 |
0.444 |
|
| 2012 |
Allen A, King A, Hollander E. Obsessive-compulsive spectrum disorders. Dialogues in Clinical Neuroscience. 5: 259-71. PMID 22033547 |
0.443 |
|
| 2012 |
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, et al. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 42: 432-40. PMID 21667200 DOI: 10.1007/S10803-011-1251-8 |
0.418 |
|
| 2012 |
Hollander E. A unique look at women and mood disorders. Cns Spectrums. 4: 9. PMID 18438306 DOI: 10.1017/S109285290001227X |
0.408 |
|
| 2012 |
Hollander E. New research in impulsive and compulsive disorders. Cns Spectrums. 4: 9. PMID 18311102 DOI: 10.1017/S109285290000674X |
0.462 |
|
| 2012 |
Hollander E, Mucci RT, Mucci CB. The obsessive compulsive spectrum: a survey of 800 practitioners. Cns Spectrums. 5: 61-4. PMID 18192941 DOI: 10.1017/S1092852900007550 |
0.497 |
|
| 2012 |
Antar LN, Ferretti CJ, Hollander E. Immune Response and Inflammation in Autism Spectrum Disorder Psychiatric Annals. 42: 342-346. DOI: 10.3928/00485713-20120906-08 |
0.421 |
|
| 2012 |
Antar LN, Hollander E. This Issue: Case Challenges in Autism Spectrum Disorder Psychiatric Annals. 42: 284-285. DOI: 10.3928/00485713-20120806-03 |
0.45 |
|
| 2012 |
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Erratum: Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care (International Journal of Psychiatry in Clinical Practice (2012) 16 (77-84)) International Journal of Psychiatry in Clinical Practice. 16. DOI: 10.3109/13651501.2012.700008 |
0.492 |
|
| 2011 |
Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. Plos One. 6: e28044. PMID 22132206 DOI: 10.1371/Journal.Pone.0028044 |
0.307 |
|
| 2011 |
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Research. 194: 230-4. PMID 22079057 DOI: 10.1016/J.Pscychresns.2011.04.007 |
0.38 |
|
| 2011 |
Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E. Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology. 36: 1418-21. PMID 21546164 DOI: 10.1016/J.Psyneuen.2011.03.013 |
0.657 |
|
| 2011 |
Fineberg NA, Chamberlain SR, Hollander E, Boulougouris V, Robbins TW. Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. British Journal of Pharmacology. 164: 1044-61. PMID 21486280 DOI: 10.1111/J.1476-5381.2011.01422.X |
0.41 |
|
| 2011 |
Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research. 1380: 198-205. PMID 21185269 DOI: 10.1016/J.Brainres.2010.12.057 |
0.33 |
|
| 2011 |
Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience. 6: 556-63. PMID 21115541 DOI: 10.1093/Scan/Nsq085 |
0.703 |
|
| 2011 |
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 72: 716-21. PMID 20816027 DOI: 10.4088/Jcp.09M05266Gre |
0.394 |
|
| 2011 |
Morgenstern J, Muench F, O'Leary A, Wainberg M, Parsons JT, Hollander E, Blain L, Irwin T. Non-paraphilic compulsive sexual behavior and psychiatric co-morbidities in gay and bisexual men Sexual Addiction and Compulsivity. 18: 114-134. DOI: 10.1080/10720162.2011.593420 |
0.331 |
|
| 2010 |
Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. The British Journal of Psychiatry : the Journal of Mental Science. 197: 330-1. PMID 20884959 DOI: 10.1192/Bjp.Bp.110.078105 |
0.33 |
|
| 2010 |
Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A, Ochsner KN. Oxytocin selectively improves empathic accuracy. Psychological Science. 21: 1426-8. PMID 20855907 DOI: 10.1177/0956797610383439 |
0.595 |
|
| 2010 |
Green JJ, Hollander E. Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 250-7. PMID 20643377 DOI: 10.1016/J.Nurt.2010.05.006 |
0.394 |
|
| 2010 |
Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum MS. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology. 62: 132-8. PMID 20588072 DOI: 10.1159/000317286 |
0.376 |
|
| 2010 |
Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder. Comprehensive Psychiatry. 51: 373-9. PMID 20579510 DOI: 10.1016/J.Comppsych.2009.10.001 |
0.387 |
|
| 2010 |
Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depression and Anxiety. 27: 528-55. PMID 20533367 DOI: 10.1002/Da.20705 |
0.511 |
|
| 2010 |
Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. The Journal of Clinical Psychiatry. 71: 784-92. PMID 20492845 DOI: 10.4088/Jcp.09M05911Blu |
0.503 |
|
| 2010 |
Bernardi S, Cortese S, Solanto M, Hollander E, Pallanti S. Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traits. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 656-66. PMID 20353313 DOI: 10.3109/15622971003653238 |
0.404 |
|
| 2010 |
Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety. 27: 507-27. PMID 20217853 DOI: 10.1002/Da.20669 |
0.457 |
|
| 2010 |
Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 990-8. PMID 20010551 DOI: 10.1038/Npp.2009.202 |
0.425 |
|
| 2010 |
Dell'Osso B, Buoli M, Hollander E, Altamura AC. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 59-65. PMID 20001657 DOI: 10.3109/15622970903418544 |
0.516 |
|
| 2010 |
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 591-604. PMID 19940844 DOI: 10.1038/Npp.2009.185 |
0.418 |
|
| 2010 |
Pallanti S, Bernardi S, Allen A, Hollander E. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan. Journal of Psychopharmacology (Oxford, England). 24: 1802-9. PMID 19825906 DOI: 10.1177/0269881109106907 |
0.317 |
|
| 2010 |
Fineberg N, Stein D, Legault M, Marteau F, Hollander E. P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse European Neuropsychopharmacology. 20: S520-S521. DOI: 10.1016/S0924-977X(10)70778-1 |
0.49 |
|
| 2009 |
Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E, Dunn JD, Culpepper L, Knispel J, Dougherty DD, Wang Z. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder. Cns Spectrums. 14: 695-703. PMID 20394177 DOI: 10.1017/S1092852900023956 |
0.491 |
|
| 2009 |
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study. Cns Drugs. 23: 1047-55. PMID 19958042 DOI: 10.2165/11530240-000000000-00000 |
0.371 |
|
| 2009 |
Hollander E, Wang AT, Braun A, Marsh L. Neurological considerations: autism and Parkinson's disease. Psychiatry Research. 170: 43-51. PMID 19815296 DOI: 10.1016/J.Psychres.2008.07.014 |
0.451 |
|
| 2009 |
Hollander E, Kim S, Braun A, Simeon D, Zohar J. Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Research. 170: 3-6. PMID 19811839 DOI: 10.1016/J.Psychres.2008.07.015 |
0.534 |
|
| 2009 |
Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA. Obsessive-compulsive disorder: diagnostic and treatment issues. The Psychiatric Clinics of North America. 32: 665-85. PMID 19716996 DOI: 10.1016/J.Psc.2009.05.007 |
0.547 |
|
| 2009 |
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 66: 583-90. PMID 19487623 DOI: 10.1001/Archgenpsychiatry.2009.30 |
0.389 |
|
| 2009 |
Smith CJ, Lang CM, Kryzak L, Reichenberg A, Hollander E, Silverman JM. Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 50: 982-90. PMID 19298470 DOI: 10.1111/J.1469-7610.2009.02060.X |
0.34 |
|
| 2008 |
Hollander E, Abramowitz JS, Koran LM, Pallanti S. Obsessive-compulsive disorder: Strategies for optimal treatment Journal of Clinical Psychiatry. 69: 1647-1657. PMID 19192448 DOI: 10.4088/Jcp.V69N1015 |
0.449 |
|
| 2008 |
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807 |
0.693 |
|
| 2008 |
Cai G, Edelmann L, Goldsmith JE, Cohen N, Nakamine A, Reichert JG, Hoffman EJ, Zurawiecki DM, Silverman JM, Hollander E, Soorya L, Anagnostou E, Betancur C, Buxbaum JD. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. Bmc Medical Genomics. 1: 50. PMID 18925931 DOI: 10.1186/1755-8794-1-50 |
0.321 |
|
| 2008 |
Pallanti S, Hollander E. Obsessive-compulsive disorder spectrum as a scientific "metaphor". Cns Spectrums. 13: 6-15. PMID 18849906 DOI: 10.1017/S1092852900026882 |
0.522 |
|
| 2008 |
Hollander E. New insights into bipolar disorder. Cns Spectrums. 13: 743. PMID 18849891 DOI: 10.1017/S1092852900013833 |
0.479 |
|
| 2008 |
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 58: 37-47. PMID 18781089 DOI: 10.1159/000154478 |
0.34 |
|
| 2008 |
Soorya L, Kiarashi J, Hollander E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 753-71, viii. PMID 18775368 DOI: 10.1016/J.Chc.2008.06.003 |
0.41 |
|
| 2008 |
Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. The Mount Sinai Journal of Medicine, New York. 75: 174-203. PMID 18704978 DOI: 10.1002/Msj.20045 |
0.501 |
|
| 2008 |
Hollander E. New developments in autism spectrum disorders. Interview by Dr. George Lundberg. Medscape Journal of Medicine. 10: 152. PMID 18679531 |
0.367 |
|
| 2008 |
Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders Progress in Brain Research. 170: 451-462. PMID 18655901 DOI: 10.1016/S0079-6123(08)00435-4 |
0.683 |
|
| 2008 |
Hollander E. Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion. Cns Spectrums. 13: 459-60. PMID 18567970 DOI: 10.1017/S1092852900016679 |
0.37 |
|
| 2008 |
Hollander E. Trauma, multiple sclerosis, delayed sleep phase disorder, subjective experiences, and duration of illness in GAD. Cns Spectrums. 13: 361-2. PMID 18496473 DOI: 10.1017/S1092852900016497 |
0.379 |
|
| 2008 |
Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology. 18: 157-78. PMID 18439113 DOI: 10.1089/Cap.2007.0041 |
0.355 |
|
| 2008 |
Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depression and Anxiety. 25: 317-29. PMID 18412058 DOI: 10.1002/da.20500 |
0.419 |
|
| 2008 |
Hollander E. Brain stimulation, alternative medicine, and impulsivity and compulsivity. Cns Spectrums. 13: 271-2. PMID 18408644 DOI: 10.1017/S1092852900016357 |
0.435 |
|
| 2008 |
Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression Journal of Clinical Psychiatry. 69: 246-258. PMID 18363453 DOI: 10.4088/Jcp.V69N0211 |
0.337 |
|
| 2008 |
Pallanti S, Masetti S, Bernardi S, Innocenti A, Markella M, Hollander E. Obsessive compulsive disorder comorbidity in DBA. Clinical Practice and Epidemiology in Mental Health : Cp & Emh. 4: 6. PMID 18331650 DOI: 10.1186/1745-0179-4-6 |
0.441 |
|
| 2008 |
Dell'Osso B, Allen A, Altamura AC, Buoli M, Hollander E. Impulsive-compulsive buying disorder: clinical overview. The Australian and New Zealand Journal of Psychiatry. 42: 259-66. PMID 18330768 DOI: 10.1080/00048670701881561 |
0.478 |
|
| 2008 |
Phillips KA, Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. 5: 13-27. PMID 18325859 DOI: 10.1016/J.Bodyim.2007.12.003 |
0.412 |
|
| 2008 |
Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. The Journal of Clinical Psychiatry. 69: 452-6. PMID 18312057 DOI: 10.4088/Jcp.V69N0316 |
0.358 |
|
| 2008 |
Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL, Hollander E. An open-label trial of venlafaxine in body dysmorphic disorder. Cns Spectrums. 13: 138-44. PMID 18227745 DOI: 10.1017/S1092852900016291 |
0.405 |
|
| 2008 |
Hollander E. Obsessive-compulsive spectrum phenomena and the DSM-V developmental process. Cns Spectrums. 13: 107-8. PMID 18227740 DOI: 10.1017/S1092852900016229 |
0.311 |
|
| 2008 |
Hollander E. Happy New 2008: from mild cognitive impairment to pleasure circuitry. Cns Spectrums. 13: 17-8. PMID 18204408 DOI: 10.1017/S1092852900016084 |
0.372 |
|
| 2008 |
Díaz-Marsá M, Carrasco JL, Basurte E, Sáiz J, López-Ibor JJ, Hollander E. Enhanced cortisol suppression in eating disorders with impulsive personality features. Psychiatry Research. 158: 93-7. PMID 18182170 DOI: 10.1016/J.Psychres.2007.06.020 |
0.482 |
|
| 2008 |
Hollander E, Bartz J, Berlin H, Allen A, Buchsbaum M, Braun A, Simeon D. S.06.01 The obsessive-compulsive spectrum disorders European Neuropsychopharmacology. 18: S165. DOI: 10.1016/S0924-977X(08)70141-X |
0.74 |
|
| 2008 |
Bartz JA, Young LJ, Hollander E, Buxbaum JD, Ring RH. Preclinical animal models of autistic spectrum disorders (ASD) Animal and Translational Models For Cns Drug Discovery. 1: 353-394. DOI: 10.1016/B978-0-12-373861-5.00011-4 |
0.699 |
|
| 2008 |
Evers M, Hollander E. Excitotoxicity in Autism Autism. 133-145. DOI: 10.1007/978-1-60327-489-0_6 |
0.484 |
|
| 2007 |
Buxbaum JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J, RÃ¥stam M, Silverman JM, Hollander E, Gillberg C, Leboyer M, Betancur C. Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephaly. Bmc Medical Genetics. 8: 68. PMID 18001468 DOI: 10.1186/1471-2350-8-68 |
0.361 |
|
| 2007 |
Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 164: 5-53. PMID 17849776 |
0.361 |
|
| 2007 |
Simeon D, Baker B, Chaplin W, Braun A, Hollander E. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. Cns Spectrums. 12: 439-43. PMID 17545954 DOI: 10.1017/S1092852900015315 |
0.393 |
|
| 2007 |
Josephson SC, Hollander E, Sumner J. Comprehensive treatment of three patients with comorbid OCPD and ADHD Cns Spectrums. 12: 338-342. PMID 17514078 DOI: 10.1017/S1092852900021131 |
0.447 |
|
| 2007 |
Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 484-91. PMID 17427195 DOI: 10.1002/Ajmg.B.30493 |
0.316 |
|
| 2007 |
Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, ... ... Hollander E, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics. 39: 319-28. PMID 17322880 DOI: 10.1038/Ng1985 |
0.315 |
|
| 2007 |
Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. International Journal of Clinical Practice. 61: 98-104. PMID 17229184 DOI: 10.1111/J.1742-1241.2006.01167.X |
0.539 |
|
| 2007 |
Simeon D, Knutelska M, Smith L, Baker BR, Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Research. 149: 177-84. PMID 17169436 DOI: 10.1016/J.Psychres.2005.11.014 |
0.317 |
|
| 2007 |
Mick TM, Hollander E. Impulsive-compulsive sexual behavior. Cns Spectrums. 11: 944-55. PMID 17146408 DOI: 10.1017/S1092852900015133 |
0.48 |
|
| 2007 |
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 61: 498-503. PMID 16904652 DOI: 10.1016/J.Biopsych.2006.05.030 |
0.677 |
|
| 2007 |
Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B. Pharmacological treatments of pathological gambling. Journal of Gambling Studies. 21: 99-110. PMID 15789195 DOI: 10.1007/s10899-004-1932-8 |
0.322 |
|
| 2007 |
Hollander E. New Uses for Old Drugs and New Circuits for Old Disorders Cns Spectrums. 12: 799-800. DOI: 10.1017/S1092852900015509 |
0.353 |
|
| 2007 |
Hollander E, Kim S, Khanna S, Pallanti S. Obsessive-Compulsive Disorder and Obsessive-Compulsive Spectrum Disorders: Diagnostic and Dimensional Issues Cns Spectrums. 12: 5-13. DOI: 10.1017/S1092852900002467 |
0.538 |
|
| 2007 |
Zohar J, Westenberg H, Stein D, Hollander E. The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder European Psychiatry. 22: S295. DOI: 10.1016/J.Eurpsy.2007.01.999 |
0.568 |
|
| 2006 |
Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. Cns Spectrums. 11: 956-64. PMID 17146409 DOI: 10.1017/S1092852900015145 |
0.342 |
|
| 2006 |
Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, Novotny S. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology. 16: 541-8. PMID 17069543 DOI: 10.1089/Cap.2006.16.541 |
0.395 |
|
| 2006 |
Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. International Clinical Psychopharmacology. 21: 363-7. PMID 17012983 DOI: 10.1097/01.Yic.0000224787.13782.0F |
0.327 |
|
| 2006 |
Hollander E, Allen A. Is compulsive buying a real disorder, and is it really compulsive? The American Journal of Psychiatry. 163: 1670-2. PMID 17012670 DOI: 10.1176/Ajp.2006.163.10.1670 |
0.504 |
|
| 2006 |
Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Clinical Neuroscience. 256: 464-75. PMID 16960655 DOI: 10.1007/S00406-006-0668-0 |
0.468 |
|
| 2006 |
Bartz JA, Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Hormones and Behavior. 50: 518-28. PMID 16884725 DOI: 10.1016/J.Yhbeh.2006.06.018 |
0.712 |
|
| 2006 |
Anagnostou E, Esposito K, Soorya L, Chaplin W, Wasserman S, Hollander E. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of Clinical Psychopharmacology. 26: 444-6. PMID 16855475 DOI: 10.1097/01.Jcp.0000227703.72117.Bc |
0.49 |
|
| 2006 |
Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. The American Journal of Psychiatry. 163: 1252-63. PMID 16816232 DOI: 10.1176/Appi.Ajp.163.7.1252 |
0.378 |
|
| 2006 |
Dell'Osso B, Nestadt G, Allen A, Hollander E. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. The Journal of Clinical Psychiatry. 67: 600-10. PMID 16669725 DOI: 10.4088/Jcp.V67N0411 |
0.433 |
|
| 2006 |
Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. The Journal of Clinical Psychiatry. 67: 407-14. PMID 16649827 DOI: 10.4088/Jcp.V67N0311 |
0.491 |
|
| 2006 |
Hollander E, Dell'Osso B. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. International Clinical Psychopharmacology. 21: 189-91. PMID 16528143 DOI: 10.1097/01.Yic.0000199453.54799.Cc |
0.401 |
|
| 2006 |
Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 338-352. PMID 16455175 DOI: 10.1016/J.Pnpbp.2005.11.003 |
0.764 |
|
| 2006 |
Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. The American Journal of Psychiatry. 163: 303-12. PMID 16449486 DOI: 10.1176/Appi.Ajp.163.2.303 |
0.322 |
|
| 2006 |
Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry. 11: 495-504. PMID 16432526 DOI: 10.1038/Sj.Mp.4001798 |
0.345 |
|
| 2006 |
Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 472-7. PMID 16387985 DOI: 10.1176/Jnp.17.4.472 |
0.453 |
|
| 2006 |
Dell'Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. Cns Spectrums. 10: 966-79, 983. PMID 16344833 DOI: 10.1017/S1092852900010531 |
0.386 |
|
| 2006 |
Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 209-13. PMID 16316486 DOI: 10.1017/S1461145705005791 |
0.501 |
|
| 2006 |
Dell'Osso B, Allen A, Hollander E. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Expert Opinion On Pharmacotherapy. 6: 2727-40. PMID 16316311 DOI: 10.1517/14656566.6.15.2727 |
0.41 |
|
| 2006 |
Hollander E. Obsessive-compulsive Disorder Psychiatric Annals. 36. DOI: 10.3928/00485713-20060701-06 |
0.517 |
|
| 2006 |
Hollander E, Alterman R, Dell’Osso B. Approaching Treatment-Resistant Obsessive-compulsive Disorder With Brain Stimulation Interventions: The State of the Art Psychiatric Annals. 36. DOI: 10.3928/00485713-20060701-01 |
0.366 |
|
| 2006 |
Hollander E. Acting on Impulse: What's New About Impulse Control Disorders and Why Would We Consider Them Forms of Behavioral Addiction? Cns Spectrums. 11: 903-904. DOI: 10.1017/S1092852900015066 |
0.431 |
|
| 2006 |
Dell' Osso B, Altamura A, Hadley S, Baker B, Hollander E. An open-label trial of escitalopram in the treatment of impulsive-compulsive internet usage disorder European Neuropsychopharmacology. 16: S82-S83. DOI: 10.1016/S0924-977X(06)80097-0 |
0.454 |
|
| 2006 |
Hollander E. C.16.01 Anxiety spectrum disorders over life cycle European Neuropsychopharmacology. 16: S585-S586. DOI: 10.1016/S0924-977X(06)70856-2 |
0.306 |
|
| 2005 |
Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review. Clinical Practice and Epidemiology in Mental Health : Cp & Emh. 1: 21. PMID 16216125 DOI: 10.1186/1745-0179-1-21 |
0.509 |
|
| 2005 |
Dell'Osso B, Hollander E. The impact of comorbidity on the management of pathological gambling. Cns Spectrums. 10: 619-21. PMID 16041292 DOI: 10.1017/S109285290001957X |
0.517 |
|
| 2005 |
Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biological Psychiatry. 58: 226-32. PMID 15939406 DOI: 10.1016/J.Biopsych.2005.03.040 |
0.359 |
|
| 2005 |
Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. The American Journal of Psychiatry. 162: 621-4. PMID 15741486 DOI: 10.1176/Appi.Ajp.162.3.621 |
0.485 |
|
| 2005 |
Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? The American Journal of Psychiatry. 162: 137-45. PMID 15625212 DOI: 10.1176/appi.ajp.162.1.137 |
0.395 |
|
| 2005 |
Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 582-9. PMID 15602505 DOI: 10.1038/Sj.Npp.1300627 |
0.346 |
|
| 2005 |
Hollander E, Zohar J. Beyond refractory obsessions and anxiety states: toward remission. The Journal of Clinical Psychiatry. 3-5. PMID 15554781 |
0.441 |
|
| 2005 |
Ketter TA, Ginsberg DL, Akiskal HS, Keck PE, Weisler RH, Hirschfeld RM, Hollander E. Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data Cns Spectrums. 10: 1-2. DOI: 10.1017/S1092852900023063 |
0.388 |
|
| 2005 |
Liebowitz MR, Ninan PT, Schneier FR, Blanco C, Ginsberg DL, Hollander E. Integrating Neurobiology and Psychopathology into Evidence-Based Treatment of Social Anxiety Disorder Cns Spectrums. 10: 1-2. DOI: 10.1017/S1092852900010336 |
0.647 |
|
| 2005 |
Costa P, Samuels J, Bagby M, Daffin L, Norton H, Gabbard GO, Rothenberg A, Shapiro D, Serpell L, Hirani V, Hollander E, Sharma L, Hand I, Fricke S, Nestadt G, et al. Obsessive-Compulsive Personality Disorder: A Review Personality Disorders. 405-477. DOI: 10.1002/0470090383.ch6 |
0.371 |
|
| 2004 |
Novotny S, Hollander E, Phillips A, Allen A, Wasserman S, Iyengar R. Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 249-54. PMID 15132762 DOI: 10.1017/S146114570400433X |
0.467 |
|
| 2004 |
Kaplan A, Hollander E. Comorbidity in compulsive hoarding: a case report. Cns Spectrums. 9: 71-3. PMID 14999178 DOI: 10.1017/S1092852900008385 |
0.5 |
|
| 2004 |
Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP. WCA recommendations for the long-term treatment of panic disorder. Cns Spectrums. 8: 17-30. PMID 14767395 DOI: 10.1017/S109285290000691X |
0.514 |
|
| 2004 |
Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. Cns Spectrums. 8: 7-16. PMID 14767394 DOI: 10.1017/S1092852900006908 |
0.432 |
|
| 2004 |
Simeon D, Nelson D, Elias R, Greenberg J, Hollander E. Relationship of personality to dissociation and childhood trauma in borderline personality disorder. Cns Spectrums. 8: 755-62. PMID 14712173 DOI: 10.1017/S109285290001912X |
0.392 |
|
| 2004 |
Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. The American Journal of Psychiatry. 161: 53-8. PMID 14702250 DOI: 10.1176/Appi.Ajp.161.1.53 |
0.34 |
|
| 2004 |
Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N, Reichert JG. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Molecular Psychiatry. 9: 144-50. PMID 14699429 DOI: 10.1038/Sj.Mp.4001465 |
0.308 |
|
| 2004 |
Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham DB. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. The Journal of Clinical Psychiatry. 64: 1113-21. PMID 14628989 DOI: 10.4088/Jcp.V64N0919 |
0.408 |
|
| 2004 |
Allen A, Hollander E. Similarities and Differences Between Body Dysmorphic Disorder and Other Disorders Psychiatric Annals. 34: 927-933. DOI: 10.3928/0048-5713-20041201-15 |
0.495 |
|
| 2004 |
Hollander E, Bartz J. A 48-year-old Man With a History of Obsessive-compulsive Disorder, Comorbid Bipolar, Panic Disorders Psychiatric Annals. 31: 808-810. DOI: 10.3928/0048-5713-20041101-04 |
0.743 |
|
| 2004 |
Kaplan A, Hollander E. A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder Focus. 2: 454-461. DOI: 10.1176/FOC.2.3.454 |
0.385 |
|
| 2004 |
Hollander E. Introduction: The Impact and Management of the Bipolar Spectrum in 2004 Cns Spectrums. 9: 5-5. DOI: 10.1017/S1092852900028832 |
0.506 |
|
| 2004 |
Hollander E, Robinson R, Compton D. New Developments in Autism Clinical Trials Cns Spectrums. 9: 20-21. DOI: 10.1017/S1092852900008324 |
0.36 |
|
| 2004 |
Hollander E. Mood and Anxiety Disorders: Special Considerations in Women Cns Spectrums. 9: 4-4. DOI: 10.1017/S1092852900002315 |
0.432 |
|
| 2003 |
Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of generalized anxiety disorder. Cns Spectrums. 8: 53-61. PMID 14767398 DOI: 10.1017/S1092852900006945 |
0.499 |
|
| 2003 |
Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of social phobia. Cns Spectrums. 8: 40-52. PMID 14767397 DOI: 10.1017/S1092852900006933 |
0.507 |
|
| 2003 |
Stein DJ, Bandelow B, Hollander E, Nutt DJ, Okasha A, Pollack MH, Swinson RP, Zohar J. WCA Recommendations for the long-term treatment of posttraumatic stress disorder. Cns Spectrums. 8: 31-9. PMID 14767396 DOI: 10.1017/S1092852900006921 |
0.487 |
|
| 2003 |
Hollander E, Phillips AT, Yeh CC. Targeted treatments for symptom domains in child and adolescent autism. Lancet (London, England). 362: 732-4. PMID 12957098 DOI: 10.1016/S0140-6736(03)14236-5 |
0.362 |
|
| 2003 |
Kaplan A, Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatric Services (Washington, D.C.). 54: 1111-8. PMID 12883138 DOI: 10.1176/Appi.Ps.54.8.1111 |
0.501 |
|
| 2003 |
Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 64: 640-7. PMID 12823077 DOI: 10.4088/Jcp.V64N0604 |
0.382 |
|
| 2003 |
Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. Venlafaxine in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 64: 546-50. PMID 12755657 DOI: 10.4088/Jcp.V64N0508 |
0.46 |
|
| 2003 |
Hollander E, Tracy KA, Swann AC, Coccaro EF, McElroy SL, Wozniak P, Sommerville KW, Nemeroff CB. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1186-97. PMID 12700713 DOI: 10.1038/Sj.Npp.1300153 |
0.46 |
|
| 2003 |
Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Current Psychiatry Reports. 5: 9-15. PMID 12685996 DOI: 10.1007/S11920-003-0003-7 |
0.461 |
|
| 2003 |
Hollander E, Kahn J. Review: in obsessive-compulsive disorder, clomipramine may be more effective than selective serotonin reuptake inhibitors after controlling for other factors. Evidence-Based Mental Health. 6: 23. PMID 12588829 DOI: 10.1136/Ebmh.6.1.23 |
0.423 |
|
| 2003 |
Hollander E, Kaplan A, Stahl SM. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 4: 30-4. PMID 12582975 DOI: 10.3109/15622970309167908 |
0.464 |
|
| 2003 |
Hollander E, King A, Delaney K, Smith CJ, Silverman JM. Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Research. 117: 11-6. PMID 12581816 DOI: 10.1016/S0165-1781(02)00304-9 |
0.362 |
|
| 2003 |
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 171-99. PMID 12516310 DOI: 10.3109/15622970209150621 |
0.389 |
|
| 2003 |
Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 193-8. PMID 12496956 DOI: 10.1038/Sj.Npp.1300021 |
0.448 |
|
| 2003 |
Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J. Treatment non-response in OCD: methodological issues and operational definitions. The International Journal of Neuropsychopharmacology. 5: 181-91. PMID 12135542 DOI: 10.1017/S1461145702002900 |
0.459 |
|
| 2003 |
Hollander E, Samons DM. Efficacy of paroxetine for relapse prevention in social anxiety disorder Current Psychiatry Reports. 5: 249-249. DOI: 10.1007/S11920-003-0052-Y |
0.445 |
|
| 2002 |
Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. The Journal of Clinical Psychiatry. 63: 1034-9. PMID 12444818 DOI: 10.4088/JCP.v63n1114 |
0.321 |
|
| 2002 |
Hadley SJ, Greenberg J, Hollander E. Diagnosis and treatment of body dysmorphic disorder in adolescents. Current Psychiatry Reports. 4: 108-13. PMID 11914171 DOI: 10.1007/S11920-002-0043-4 |
0.341 |
|
| 2002 |
Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M, Buxbaum JD, Delaney K, Galvin P. Symptom domains in autism and related conditions: evidence for familiality. American Journal of Medical Genetics. 114: 64-73. PMID 11840508 DOI: 10.1002/Ajmg.10048 |
0.317 |
|
| 2002 |
Mathew SJ, Coplan JD, Perko KA, Goetz RR, de la Neuz M, Hollander E, Liebowitz MR, Fallon BA. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. Depression and Anxiety. 14: 199-208. PMID 11754126 DOI: 10.1002/Da.1067 |
0.33 |
|
| 2001 |
Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder Neuropsychopharmacology. 25: 793-795. PMID 11682263 DOI: 10.1016/S0893-133X(01)00288-3 |
0.42 |
|
| 2001 |
Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. The Journal of Clinical Psychiatry. 62: 530-4. PMID 11488363 DOI: 10.4088/Jcp.V62N07A05 |
0.456 |
|
| 2001 |
Buchsbaum MS, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 4: 119-25. PMID 11466160 DOI: 10.1017/S1461145701002280 |
0.389 |
|
| 2001 |
Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. The Journal of Clinical Psychiatry. 62: 199-203. PMID 11305707 DOI: 10.4088/Jcp.V62N0311 |
0.557 |
|
| 2001 |
Vythilingum B, Cartwright C, Hollander E. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors. International Clinical Psychopharmacology. S7-13. PMID 11110014 DOI: 10.1097/00004850-200008002-00003 |
0.408 |
|
| 2001 |
Mathew SJ, Coplan JD, Perko KA, Goetz RR, Neuz Mdl, Hollander E, Liebowitz MR, Fallon BA. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive–compulsive disorder Presented in part at the 2000 APA meeting May, Chicago, Illinois, Young Investigators Poster, and the 2001 ADAA Conference in Atlanta, Georgia Depression and Anxiety. 14: 199. DOI: 10.1002/Da.1067.Abs |
0.42 |
|
| 2000 |
Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. The American Journal of Psychiatry. 157: 1994-2001. PMID 11097966 DOI: 10.1176/Appi.Ajp.157.12.1994 |
0.4 |
|
| 2000 |
Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum MS. Feeling unreal: a PET study of depersonalization disorder. The American Journal of Psychiatry. 157: 1782-8. PMID 11058475 DOI: 10.1176/Appi.Ajp.157.11.1782 |
0.401 |
|
| 2000 |
Hollander E, Kaplan A, Allen A, Cartwright C. Pharmacotherapy for obsessive-compulsive disorder. The Psychiatric Clinics of North America. 23: 643-56. PMID 10986733 DOI: 10.1016/S0193-953X(05)70186-6 |
0.389 |
|
| 2000 |
Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. The Psychiatric Clinics of North America. 23: 629-42. PMID 10986732 DOI: 10.1016/s0193-953x(05)70185-4 |
0.365 |
|
| 2000 |
Marazziti D, Masala I, Rossi A, Hollander E, Presta S, Giannaccini G, Mazzoni MR, Dell'Osso L, Lucacchini A, Cassano GB. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD. Neuropsychobiology. 41: 171-7. PMID 10828725 DOI: 10.1159/000026656 |
0.302 |
|
| 2000 |
Novotny S, Hollander E, Allen A, Mosovich S, Aronowitz B, Cartwright C, DeCaria C, Dolgoff-Kaspar R. Increased growth hormone response to sumatriptan challenge in adult autistic disorders. Psychiatry Research. 94: 173-7. PMID 10808042 DOI: 10.1016/S0165-1781(00)00134-7 |
0.363 |
|
| 2000 |
Carrasco JL, Díaz-Marsá M, Hollander E, César J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female bulimia nervosa. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 113-7. PMID 10706992 DOI: 10.1016/S0924-977X(99)00061-9 |
0.363 |
|
| 2000 |
Hollander E, Kaplan A, Cartwright C, Reichman D. Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. Journal of Child Neurology. 15: 132-5. PMID 10695900 DOI: 10.1177/088307380001500214 |
0.466 |
|
| 2000 |
Stein DJ, Hollander E, Simeon D, Cohen L. Impulsivity scores in patients with obsessive-compulsive disorder. The Journal of Nervous and Mental Disease. 182: 240-1. PMID 10678323 DOI: 10.1097/00005053-199404000-00009 |
0.511 |
|
| 2000 |
Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 163-7. PMID 10649829 DOI: 10.1016/S0893-133X(99)00121-9 |
0.399 |
|
| 2000 |
Diaz-Marsa M, Carrasco JL, Hollander E, Cesar J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female anorexia nervosa Acta Psychiatrica Scandinavica. 101: 226-230. DOI: 10.1034/J.1600-0447.2000.101003226.X |
0.387 |
|
| 2000 |
Stein DJ, Allen A, Bobes J, Eisen JL, Figuera ML, Iikura Y, Koran LM, Hollander E. Quality of Life in Obsessive-Compulsive Disorder Cns Spectrums. 5: 37-39. DOI: 10.1017/S1092852900025025 |
0.517 |
|
| 2000 |
Hollander E, Zohar J, Marazziti D. The Fourth IOCDC Cns Spectrums. 5: 4-4. DOI: 10.1017/S1092852900024950 |
0.38 |
|
| 2000 |
Hollander E. Exploring the Boundaries of Anxiety and Psychosis Cns Spectrums. 5: 17-17. DOI: 10.1017/S1092852900021581 |
0.491 |
|
| 2000 |
Hollander E, Twersky R. Body dysmorphic disorder: assessment and treatment with serotonergic drugs European Neuropsychopharmacology. 10: 125-126. DOI: 10.1016/S0924-977X(00)80022-X |
0.413 |
|
| 2000 |
Novotny S, Hollander E, Allen A, Aronowitz B, DeCaria C, Cartwright C, Yaffe R. 523. Behavioral response to oxytocin challenge in adult autistic disorders Biological Psychiatry. 47: S159. DOI: 10.1016/S0006-3223(00)00793-9 |
0.424 |
|
| 1999 |
Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, Simeon D. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry. 56: 1033-9. PMID 10565503 DOI: 10.1001/Archpsyc.56.11.1033 |
0.494 |
|
| 1999 |
Hollander E, DelGiudice-Asch G, Simon L, Schmeidler J, Cartwright C, DeCaria CM, Kwon J, Cunningham-Rundles C, Chapman F, Zabriskie JB. B lymphocyte antigen D8/17 and repetitive behaviors in autism. The American Journal of Psychiatry. 156: 317-20. PMID 9989573 DOI: 10.1176/Ajp.156.2.317 |
0.315 |
|
| 1999 |
Cartwright C, Hollander E. SSRIs in the treatment of obsessive-compulsive disorder. Depression and Anxiety. 105-13. PMID 9809222 DOI: 10.1002/(Sici)1520-6394(1998)8:1+<105::Aid-Da16>3.0.Co;2-T |
0.439 |
|
| 1999 |
Rauch SL, Benkelfat C, Dager SR, Greenberg BD, Hendler T, Hollander E, Laruelle M, Rosenberg DR, Saxena S, Zohar J, Baxter L.R. J. Neuroimaging research and neurocircuitry models of obsessive-compulsive disorder: Proceedings of the Third IOCDC Cns Spectrums. 4: 25-34. DOI: 10.1017/S1092852900007392 |
0.455 |
|
| 1999 |
Hollander E, Rosen J. OC Spectrum Disorders: The Impulsive and Schizo-Obsessive Clusters Cns Spectrums. 4: 16-21. DOI: 10.1017/S1092852900007379 |
0.412 |
|
| 1999 |
Hollander E. The Neuroscience of the Tourette Syndrome Spectrum Cns Spectrums. 4: 13-13. DOI: 10.1017/S1092852900000754 |
0.362 |
|
| 1998 |
Simeon D, Guralnik O, Gross S, Stein DJ, Schmeidler J, Hollander E. The detection and measurement of depersonalization disorder. The Journal of Nervous and Mental Disease. 186: 536-42. PMID 9741559 DOI: 10.1097/00005053-199809000-00004 |
0.533 |
|
| 1998 |
Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with clomipramine. Biological Psychiatry. 44: 302-3. PMID 9715363 DOI: 10.1016/S0006-3223(98)00023-7 |
0.534 |
|
| 1998 |
Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Research. 79: 213-7. PMID 9704868 DOI: 10.1016/S0165-1781(98)00041-9 |
0.461 |
|
| 1998 |
Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A double-blind trial of fluoxetine in pathologic skin picking. The Journal of Clinical Psychiatry. 58: 341-7. PMID 9515971 DOI: 10.4088/Jcp.V58N0802 |
0.362 |
|
| 1998 |
Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs British Journal of Psychiatry. 173: 7-12. DOI: 10.1192/S0007125000297845 |
0.521 |
|
| 1998 |
Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and Comorbid Obsessive-Compulsive Disorder in an Epidemiologic Sample Cns Spectrums. 3: 10-18. DOI: 10.1017/S1092852900007148 |
0.422 |
|
| 1998 |
Hollander E. New Neural Constructs for Obsessive-Compulsive Disorder Cns Spectrums. 3: 17-17. DOI: 10.1017/S1092852900006106 |
0.456 |
|
| 1998 |
Hollander E, Begaz T, DeCaria CM. Pharmacologic Approaches in the Treatment of Pathological Gambling Cns Spectrums. 3: 72-80. DOI: 10.1017/S1092852900006039 |
0.476 |
|
| 1998 |
DeCaria CM, Begaz T, Hollander E. Serotonergic and Noradrenergic Function in Pathological Gambling Cns Spectrums. 3: 38-47. DOI: 10.1017/S1092852900006003 |
0.423 |
|
| 1998 |
Hollander E, Cartwright C, Wong CM, Decaria CM, Delgiudice-Asch G, Buchsbaum MS, Aronowitz BR. A dimensional approach to the autism spectrum Cns Spectrums. 3: 22-39. DOI: 10.1017/S1092852900005678 |
0.41 |
|
| 1998 |
Hollander E, Delgiudice-Asch G, Cartwright C, DeCaria C, Bienstock C. Auto-immune findings in OCD spectrum disorders and their implications for treatment European Neuropsychopharmacology. 8: S125. DOI: 10.1016/S0924-977X(98)80112-0 |
0.46 |
|
| 1998 |
Hollander E, DeCaria C, Cartwright C. OCD spectrum disorders — From impulsivity to compulsivity European Psychiatry. 13: 196S-196S. DOI: 10.1016/S0924-9338(99)80232-6 |
0.512 |
|
| 1998 |
Hollander E, Aronowitz B, DeCaria C, Wong C, Cartwright C, DelGuidice-Asch G. 10. Neurobiology and treatment of autism Biological Psychiatry. 43. DOI: 10.1016/S0006-3223(98)90458-9 |
0.328 |
|
| 1997 |
Simeon D, Gross S, Guralnik O, Stein DJ, Schmeidler J, Hollander E. Feeling unreal: 30 cases of DSM-III-R depersonalization disorder. The American Journal of Psychiatry. 154: 1107-13. PMID 9247397 DOI: 10.1176/Ajp.154.8.1107 |
0.55 |
|
| 1997 |
Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depression and Anxiety. 4: 111-9. PMID 9166639 DOI: 10.1017/S1092852900007148 |
0.422 |
|
| 1997 |
Grossman R, Cohen L, Rosen J, DeCaria C, Hollander E. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder. Biological Psychiatry. 39: 982-5. PMID 9162213 DOI: 10.1016/0006-3223(95)00658-3 |
0.324 |
|
| 1997 |
Grove G, Coplan JD, Hollander E. The neuroanatomy of 5-HT dysregulation and panic disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 198-207. PMID 9144099 DOI: 10.1176/Jnp.9.2.198 |
0.458 |
|
| 1997 |
Stein DJ, Trestman RL, Mitropoulou V, Coccaro EF, Hollander E, Siever LJ. Impulsivity and serotonergic function in compulsive personality disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 393-8. PMID 9116474 DOI: 10.1176/Jnp.8.4.393 |
0.58 |
|
| 1997 |
Josephson SC, Hollander E. Body dysmorphic disorder by proxy Journal of Clinical Psychiatry. 58: 86-87. PMID 9062380 DOI: 10.4088/Jcp.V58N0206C |
0.456 |
|
| 1997 |
Simeon D, Cohen LJ, Stein DJ, Schmeidler J, Spadaccini E, Hollander E. Comorbid self-injurious behaviors in 71 female hair-pullers: a survey study. The Journal of Nervous and Mental Disease. 185: 117-9. PMID 9048705 DOI: 10.1097/00005053-199702000-00009 |
0.359 |
|
| 1997 |
Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biological Psychiatry. 40: 508-13. PMID 8879471 DOI: 10.1016/0006-3223(95)00470-X |
0.485 |
|
| 1997 |
HOLLANDER E, BENZAQUEN SD. The obsessive-compulsive spectrum disorders International Review of Psychiatry. 9: 99-110. DOI: 10.1080/09540269775628 |
0.535 |
|
| 1997 |
Cohen LJ, Stein D, Galynker I, Hollander E. Towards an integration of psychological and biological models of obsessive-compulsive disorder: Phylogenetic considerations Cns Spectrums. 2: 26-44. DOI: 10.1017/S109285290001107X |
0.506 |
|
| 1997 |
Hollander E, Stein DJ, Kwon JH, Rowland C, Wong CM, Broatch J, Himelein C. Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder Cns Spectrums. 2: 16-25. DOI: 10.1017/S1092852900011068 |
0.491 |
|
| 1997 |
Delgiudice-Asch G, Hollander E. Altered Immune Function In Autism Cns Spectrums. 2: 61-68. DOI: 10.1017/S1092852900004909 |
0.346 |
|
| 1997 |
Aronowitz BR, Decaria C, Allen A, Weiss N, Saunders A, Margolin L, Mosovich S, Baum M, Hollander E. The Neuropsychiatry of Autism and Asperger's Disorder: Review of the Literature and Case Reports Cns Spectrums. 2: 43-60. DOI: 10.1017/S1092852900004892 |
0.445 |
|
| 1997 |
Wong CM, Hollander E. Serotonin Function and Gender Effects in Migraine Production and OCD Cns Spectrums. 2: 25-27. DOI: 10.1017/S1092852900001760 |
0.403 |
|
| 1997 |
Hollander E, Wong C, DeCaria C, Aronowitz B, Margolin L. Is biological psychiatry addressing the treatment of eating disorders, OCD and OCD spectrum disorders? Biological Psychiatry. 42: 264S. DOI: 10.1016/S0006-3223(97)88029-8 |
0.524 |
|
| 1996 |
Wong CM, Hollander E. Headache response to m-chlorophenylpiperazine in obsessive-compulsive disorder and normal controls Biological Psychiatry. 40: 544-546. PMID 8879476 DOI: 10.1016/0006-3223(96)00164-3 |
0.44 |
|
| 1996 |
Cohen LJ, Hollander E, DeCaria CM, Stein DJ, Simeon D, Liebowitz MR, Aronowitz BR. Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 82-5. PMID 8845706 DOI: 10.1176/Jnp.8.1.82 |
0.657 |
|
| 1996 |
Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. Journal of Clinical Psychopharmacology. 16: 121-9. PMID 8690827 DOI: 10.1097/00004714-199604000-00004 |
0.381 |
|
| 1996 |
Milrod B, Busch FN, Hollander E, Aronson A, Siever L. A 23-year-old woman with panic disorder treated with psychodynamic psychotherapy. The American Journal of Psychiatry. 153: 698-703. PMID 8615418 DOI: 10.1176/Ajp.153.5.698 |
0.304 |
|
| 1996 |
Grossman R, Hollander E. Treatment of obsessive-compulsive disorder with venlafaxine. The American Journal of Psychiatry. 153: 576-7. PMID 8599411 DOI: 10.1176/Ajp.153.4.576B |
0.51 |
|
| 1996 |
Simeon D, Hollander E, Stein DJ, DeCaria C, Cohen LJ, Saoud JB, Islam N, Hwang M. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Research. 58: 161-4. PMID 8570768 DOI: 10.1016/0165-1781(95)02538-8 |
0.545 |
|
| 1996 |
Hollander E, Prohovnik I, Stein DJ. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 485-90. PMID 8555752 DOI: 10.1176/Jnp.7.4.485 |
0.434 |
|
| 1996 |
Hollander E, Grossman R, Stein DJ, Kwon J. Borderline Personality Disorder and Impulsive-Aggression: The Role for Divalproex Sodium Treatment Psychiatric Annals. 26: S464-S469. DOI: 10.3928/0048-5713-19960702-11 |
0.559 |
|
| 1996 |
Hollander E. Obsessive-compulsive disorder related disorders International Clinical Psychopharmacology. 11: 75-88. DOI: 10.1097/00004850-199612005-00007 |
0.536 |
|
| 1996 |
Wong CM, Hollander E. New Dimensions in the OCD Spectrum: Autism, Pathologic Gambling, and Compulsive Buying Cns Spectrums. 1: 44-53. DOI: 10.1017/S1092852900002649 |
0.509 |
|
| 1996 |
Josephson SC, Hollander E, Fallon B, Stein DJ. Obsessive-Compulsive Disorder, Body Dysmorphic Disorder, and Hypochondriasis: Three Variations on a Theme Cns Spectrums. 1: 24-31. DOI: 10.1017/S1092852900002613 |
0.607 |
|
| 1996 |
Grove G, Coplan J, Margolin L, Hollander E. The Neuroanatomy of Serotonin (5-HT) Dysregulation in Obsessive-Compulsive Disorder Cns Spectrums. 1: 16-22. DOI: 10.1017/S1092852900002595 |
0.357 |
|
| 1996 |
Hollander E, Benzaquen SD. Is There a Distinct OCD Spectrum? Cns Spectrums. 1: 17-26. DOI: 10.1017/S1092852900000651 |
0.532 |
|
| 1996 |
Hollander E, Cherkasky S, Wong C, Grossman R, DeCaria C, Aronowitz B. Maintenance treatment for obsessive-compulsive disorder Biological Psychiatry. 39: 610. DOI: 10.1016/0006-3223(96)84318-6 |
0.508 |
|
| 1995 |
Skodol AE, Oldham JM, Hyler SE, Stein DJ, Hollander E, Gallaher PE, Lopez AE. Patterns of anxiety and personality disorder comorbidity Journal of Psychiatric Research. 29: 361-374. PMID 8748061 DOI: 10.1016/0022-3956(95)00015-W |
0.595 |
|
| 1995 |
Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. The American Journal of Psychiatry. 152: 90-6. PMID 7802127 DOI: 10.1176/Ajp.152.1.90 |
0.394 |
|
| 1995 |
Stein DJ, Hollander E, Cohen L, Simeon D, Aronowitz B. Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine. Biological Psychiatry. 37: 414-6. PMID 7772651 DOI: 10.1016/0006-3223(94)00199-D |
0.346 |
|
| 1995 |
Stein DJ, Simeon D, Cohen LJ, Hollander E. Trichotillomania and obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 28-34; discussion 35. PMID 7713862 DOI: 10.1176/Ajp.150.7.1131-A |
0.608 |
|
| 1995 |
Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. The American Journal of Psychiatry. 152: 1207-9. PMID 7625473 DOI: 10.1176/Ajp.152.8.1207 |
0.588 |
|
| 1995 |
Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. International Clinical Psychopharmacology. 10: 11-8. PMID 7622800 DOI: 10.1097/00004850-199503000-00002 |
0.473 |
|
| 1995 |
Hadigan CM, Walsh BT, Buttinger C, Hollander E. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. Biological Psychiatry. 37: 504-11. PMID 7619973 DOI: 10.1016/0006-3223(94)00169-4 |
0.385 |
|
| 1995 |
Stein DJ, Mullen L, Islam MN, Cohen L, DeCaria CM, Hollander E. Compulsive and impulsive symptomatology in trichotillomania. Psychopathology. 28: 208-13. PMID 7480576 DOI: 10.1159/000284923 |
0.595 |
|
| 1995 |
Koran LM, McElroy SL, Davidson JRT, Rasmussen SA, Hollander E, Jenike MA. P-6-9 Double-blind comparison of fluvoxamine and clomipramine in obsessive compulsive disorder in the United States European Neuropsychopharmacology. 5: 371. DOI: 10.1016/0924-977X(95)90658-Z |
0.419 |
|
| 1995 |
Stein DJ, Trestman R, Coccaro E, Mitropoulou V, Hollander E, Siever L. Serotonergic responsivity in compulsive personality disorder Biological Psychiatry. 37: 645. DOI: 10.1016/0006-3223(95)94598-Q |
0.594 |
|
| 1994 |
Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM. Serotonergic sensitivity in borderline personality disorder: preliminary findings. The American Journal of Psychiatry. 151: 277-80. PMID 8296905 DOI: 10.1176/Ajp.151.2.277 |
0.526 |
|
| 1994 |
Stein DJ, Hollander E, Chan S, DeCaria CM, Hilal S, Liebowitz MR, Klein DF. Computed tomography and neurological soft signs in obsessive-compulsive disorder. Psychiatry Research. 50: 143-50. PMID 8272450 DOI: 10.1016/0925-4927(93)90026-E |
0.418 |
|
| 1994 |
Stein DJ, Hollander E, Cohen L, Frenkel M, Saoud JB, DeCaria C, Aronowitz B, Levin A, Liebowitz MR, Cohen L. Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Research. 48: 257-66. PMID 8272447 DOI: 10.1016/0165-1781(93)90076-S |
0.462 |
|
| 1994 |
Stein DJ, Keating J, Zar HJ, Hollander E. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences. 6: 23-9. PMID 8148633 DOI: 10.1176/Jnp.6.1.23 |
0.445 |
|
| 1994 |
Stein DJ, Hollander E, Simeon D, Cohen L, Islam MN, Aronowitz B. Neurological soft signs in female trichotillomania patients, obsessive-compulsive disorder patients, and healthy control subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 6: 184-7. PMID 8044043 DOI: 10.1176/Jnp.6.2.184 |
0.497 |
|
| 1994 |
Hollander E, De Caria C, Stein D, Simeon D, Cohen L, Hwang M, Islam M. Behavioral response to m-CPP. Biological Psychiatry. 35: 426-7. PMID 8018791 DOI: 10.1016/0006-3223(94)90011-6 |
0.355 |
|
| 1994 |
Stein DJ, Dodman NH, Borchelt P, Hollander E. Behavioral disorders in veterinary practice: relevance to psychiatry. Comprehensive Psychiatry. 35: 275-85. PMID 7956183 DOI: 10.1016/0010-440X(94)90019-1 |
0.535 |
|
| 1994 |
Aronowitz B, Liebowitz M, Hollander E, Fazzini E, Durlach-Misteli C, Frenkel M, Mosovich S, Garfinkel R, Saoud J, DelBene D, Cohen L, Jaeger A, Rubin AL. Neuropsychiatric and neuropsychological findings in conduct disorder and attention-deficit hyperactivity disorder Journal of Neuropsychiatry and Clinical Neurosciences. 6: 245-249. PMID 7950346 DOI: 10.1176/JNP.6.3.245 |
0.483 |
|
| 1994 |
Carrasco JL, Sáiz-Ruiz J, Hollander E, César J, López-Ibor JJ. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatrica Scandinavica. 90: 427-31. PMID 7892775 DOI: 10.1111/J.1600-0447.1994.Tb01619.X |
0.328 |
|
| 1994 |
Towey JP, Tenke CE, Bruder GE, Leite P, Friedman D, Liebowitz M, Hollander E. Brain event-related potential correlates of overfocused attention in obsessive-compulsive disorder Psychophysiology. 31: 535-543. PMID 7846214 DOI: 10.1111/J.1469-8986.1994.Tb02346.X |
0.58 |
|
| 1994 |
Stein DJ, Patterson R, Hollander E. Expert Systems for Psychiatric Pharmacotherapy Psychiatric Annals. 24: 37-41. DOI: 10.3928/0048-5713-19940101-12 |
0.392 |
|
| 1994 |
Stein DJ, Hollander E. Sexual Dysfunction Associated with the Drug Treatment of Psychiatric Disorders Cns Drugs. 2: 78-86. DOI: 10.2165/00023210-199402010-00006 |
0.397 |
|
| 1994 |
Cohen L, Hollander E, Stein D, Simeon D, Spadaccini E, Islam N, Aronowitz B. Demographic and clinical profile of 110 hairpullers Biological Psychiatry. 35: 698. DOI: 10.1016/0006-3223(94)90955-5 |
0.343 |
|
| 1994 |
Stein D, Hollander E, Cohen L, Simeon D, Aronowitz B. Serotonergic responsivity in trichotillomania Biological Psychiatry. 35: 645. DOI: 10.1016/0006-3223(94)90766-8 |
0.503 |
|
| 1994 |
Stein D, Hollander E, DeCaria C, Simeon D, Cohen L. Serotonergic responsivity in borderline personality disorder Biological Psychiatry. 35: 644. DOI: 10.1016/0006-3223(94)90765-X |
0.554 |
|
| 1994 |
Aronowitz B, Hollander E, DeCaria C, Cohen L, Stein D, Simeon D. Neuropsychology of OCD: Preliminary findings Biological Psychiatry. 35: 638. DOI: 10.1016/0006-3223(94)90742-0 |
0.468 |
|
| 1993 |
Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, DeCaria CM, Levine RH. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research. 50: 25-32. PMID 8511221 DOI: 10.1016/0925-4927(93)90021-9 |
0.561 |
|
| 1993 |
Hollander E, Hwang MY, Mullen LS, DeCaria C, Stein DJ, Cohen L. Clinical and research issues in depersonalization syndrome. Psychosomatics. 34: 193-4. PMID 8456168 DOI: 10.1016/S0033-3182(93)71919-2 |
0.355 |
|
| 1993 |
Stein DJ, Hutt CS, Spitz JL, Hollander E. Compulsive picking and obsessive-compulsive disorder. Psychosomatics. 34: 177-81. PMID 8456163 DOI: 10.1016/S0033-3182(93)71911-8 |
0.594 |
|
| 1993 |
Hollander E, Cohen L, Richards M, Mullen L, DeCaria C, Stern Y. A pilot study of the neuropsychology of obsessive-compulsive disorder and Parkinson's disease: basal ganglia disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 104-7. PMID 8428130 DOI: 10.1176/Jnp.5.1.104 |
0.425 |
|
| 1993 |
Hollander E, Stein DJ, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biological Psychiatry. 33: 747-9. PMID 8353170 DOI: 10.1016/0006-3223(93)90126-X |
0.574 |
|
| 1993 |
Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biological Psychiatry. 34: 407-13. PMID 8218609 DOI: 10.1016/0006-3223(93)90186-H |
0.361 |
|
| 1993 |
Papp LA, Klein DF, Martinez J, Schneier F, Cole R, Liebowitz MR, Hollander E, Fyer AJ, Jordan F, Gorman JM. Diagnostic and substance specificity of carbon-dioxide-induced panic. The American Journal of Psychiatry. 150: 250-7. PMID 8123056 DOI: 10.1176/Ajp.150.2.250 |
0.522 |
|
| 1993 |
Hwang MY, Martin AM, Lindenmayer JP, Stein D, Hollander E. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors. The American Journal of Psychiatry. 150: 1127. PMID 8100402 DOI: 10.1176/Ajp.150.7.1127 |
0.386 |
|
| 1993 |
Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity and the impulse control disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 9-17. PMID 7679020 DOI: 10.1176/Jnp.5.1.9 |
0.694 |
|
| 1993 |
Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Islam MN, Liebowitz MR, Stanley M. Effects of fenfluramine on plasma homovanillic acid in healthy subjects. Journal of Neural Transmission. General Section. 90: 81-4. PMID 1466879 DOI: 10.1007/Bf01250520 |
0.531 |
|
| 1993 |
Hwang MY, Hollander E. Schizo-Obsessive Disorders Psychiatric Annals. 23: 396-401. DOI: 10.3928/0048-5713-19930701-11 |
0.515 |
|
| 1993 |
Stein DJ, Hollander E. Impulsive Aggression and Obsessive-Compulsive Disorder Psychiatric Annals. 23: 389-395. DOI: 10.3928/0048-5713-19930701-10 |
0.595 |
|
| 1993 |
Hollander E. Obsessive-Compulsive Spectrum Disorders: An Overview Psychiatric Annals. 23: 355-358. DOI: 10.3928/0048-5713-19930701-05 |
0.511 |
|
| 1993 |
Stein DJ, Hollander E, Skodol AE. Anxiety Disorders and Personality Disorders: A Review Journal of Personality Disorders. 7: 87-104. DOI: 10.1521/Pedi.1993.7.2.87 |
0.582 |
|
| 1993 |
FALLON BA, LIEBOWITZ MR, SALM??N E, SCHNEIER FR, JUSINO C, HOLLANDER E, KLEIN DF. Fluoxetine for Hypochondriacal Patients Without Major Depression Journal of Clinical Psychopharmacology. 13: 438???441. DOI: 10.1097/00004714-199312000-00010 |
0.538 |
|
| 1993 |
SCHNEIER FR, SAOUD JB, CAMPEAS R, FALLON BA, HOLLANDER E, COPLAN J, LIEBOWITZ MR. Buspirone in Social Phobia Journal of Clinical Psychopharmacology. 13: 251???256. DOI: 10.1097/00004714-199308000-00004 |
0.568 |
|
| 1993 |
SCHNEIER FR, CARRASCO JL, HOLLANDER E, CAMPEAS R, FALLON B, SAOUD JB, FEERICK J, LIEBOWITZ MR. Alpidem in the Treatment of Panic Disorder Journal of Clinical Psychopharmacology. 13: 150???153. DOI: 10.1097/00004714-199304000-00011 |
0.651 |
|
| 1993 |
Hollander E, DeCaria C, Stein D, Simeon D, Hwang M, Cohen L. Preferential response of serotonergic medications in OCD related disorders European Neuropsychopharmacology. 3: 291-293. DOI: 10.1016/0924-977X(93)90079-2 |
0.597 |
|
| 1992 |
Hollander E, DeCaria CM, Aronowitz B, Klein DF, Liebowitz MR, Shaffer D. A pilot follow-up study of childhood soft signs and the development of adult psychopathology. The Journal of Neuropsychiatry and Clinical Neurosciences. 3: 186-9. PMID 1821234 DOI: 10.1176/Jnp.3.2.186 |
0.639 |
|
| 1992 |
Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry. 49: 21-8. PMID 1728249 DOI: 10.1001/Archpsyc.1992.01820010021003 |
0.588 |
|
| 1992 |
Stein DJ, Shoulberg N, Helton K, Hollander E. The neuroethological approach to obsessive-compulsive disorder. Comprehensive Psychiatry. 33: 274-81. PMID 1643870 DOI: 10.1016/0010-440X(92)90053-S |
0.52 |
|
| 1992 |
Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Trungold S, Stanley M, Liebowitz MR. Effects of fenfluramine on plasma HVA in OCD. Psychiatry Research. 42: 185-8. PMID 1631253 DOI: 10.1016/0165-1781(92)90081-D |
0.527 |
|
| 1992 |
Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 4: 70-5. PMID 1627966 DOI: 10.1176/JNP.4.1.70 |
0.556 |
|
| 1992 |
Marazziti D, Hollander E, Lensi P, Ravagli S, Cassano GB. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Research. 42: 41-51. PMID 1603880 DOI: 10.1016/0165-1781(92)90037-4 |
0.328 |
|
| 1992 |
Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry. 49: 290-300. PMID 1558463 DOI: 10.1001/Archpsyc.49.4.290 |
0.519 |
|
| 1992 |
Hollander E, Neville D, Frenkel M, Josephson S, Liebowitz MR. Body dysmorphic disorder. Diagnostic issues and related disorders. Psychosomatics. 33: 156-65. PMID 1557480 DOI: 10.1016/S0033-3182(92)71991-4 |
0.652 |
|
| 1992 |
Stein DJ, Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. Journal of the American Academy of Dermatology. 26: 237-42. PMID 1552059 DOI: 10.1016/0190-9622(92)70033-C |
0.604 |
|
| 1992 |
Schneier FR, Chin SJ, Hollander E, Liebowitz MR. Fluoxetine in social phobia. Journal of Clinical Psychopharmacology. 12: 62-4. PMID 1552041 DOI: 10.1097/00001573-199202000-00020 |
0.407 |
|
| 1992 |
Hollander E, Carrasco JL, Mullen LS, Trungold S, DeCaria CM, Towey J. Left hemispheric activation in depersonalization disorder: a case report. Biological Psychiatry. 31: 1157-62. PMID 1525279 DOI: 10.1016/0006-3223(92)90161-R |
0.499 |
|
| 1992 |
Hollander E, Stein DJ, Decaria CM, Cohen L, Islam M, Frenkel M. Disorders related to OCD--neurobiology. Clinical Neuropharmacology. 259A-260A. PMID 1498832 DOI: 10.1097/00002826-199201001-00135 |
0.583 |
|
| 1992 |
Hollander E, Cohen L, DeCaria C, Stein DJ, Trungold-Apter S, Islam M. Fluoxetine and depersonalization syndrome. Psychosomatics. 33: 361-2. PMID 1410214 DOI: 10.1016/S0033-3182(92)71984-7 |
0.344 |
|
| 1992 |
SCHNEIER FR, CHIN SJ, HOLLANDER E, LIEBOWITZ MR. Fluoxetine in Social Phobia Journal of Clinical Psychopharmacology. 12: 62???63. DOI: 10.1097/00004714-199202000-00018 |
0.407 |
|
| 1992 |
Stein DJ, Hollander E, Mullen LS, Decaria CM, Liebowitz MR. Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive?compulsive disorder Human Psychopharmacology: Clinical and Experimental. 7: 389-395. DOI: 10.1002/Hup.470070604 |
0.641 |
|
| 1991 |
Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Research. 36: 1-17. PMID 2017519 DOI: 10.1016/0165-1781(91)90113-4 |
0.604 |
|
| 1991 |
Hollander E, DeCaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Research. 37: 161-77. PMID 1876628 DOI: 10.1016/0165-1781(91)90073-X |
0.599 |
|
| 1991 |
STEIN DJ, FRENKEL M, HOLLANDER E. Classification of Koro American Journal of Psychiatry. 148: 1279-a-1280. DOI: 10.1176/Ajp.148.9.1279-A |
0.32 |
|
| 1991 |
Hollander E. Neurologic Soft Signs in Obsessive-Compulsive Disorder-Reply Archives of General Psychiatry. 48: 278. DOI: 10.1001/Archpsyc.1991.01810270090014 |
0.407 |
|
| 1990 |
Hatterer JA, Gorman JM, Fyer AJ, Campeas RB, Schneier FR, Hollander E, Papp LA, Liebowitz MR. Pharmacotherapy of four men with paruresis. The American Journal of Psychiatry. 147: 109-11. PMID 2403470 DOI: 10.1176/Ajp.147.1.109 |
0.481 |
|
| 1990 |
Towey J, Bruder G, Hollander E, Friedman D, Erhan H, Liebowitz M, Sutton S. Endogenous event-related potentials in obsessive-compulsive disorder Biological Psychiatry. 28: 92-98. PMID 2378924 DOI: 10.1016/0006-3223(90)90626-D |
0.546 |
|
| 1990 |
Hollander E, Liebowitz MR, DeCaria C, Klein DF. Fenfluramine, cortisol, and anxiety. Psychiatry Research. 31: 211-3. PMID 2360951 DOI: 10.1016/0165-1781(90)90124-N |
0.532 |
|
| 1990 |
Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF. Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology. 10: 119-21. PMID 2341585 DOI: 10.1097/00004714-199004000-00007 |
0.628 |
|
| 1990 |
Liebowitz MR, Hollander E, Fairbanks J, Campeas R. Fluoxetine for adolescents with obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 370-1. PMID 2309962 DOI: 10.1176/Ajp.147.3.370B |
0.601 |
|
| 1990 |
Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Archives of General Psychiatry. 47: 27-32. PMID 2294853 DOI: 10.1001/Archpsyc.1990.01810130029005 |
0.606 |
|
| 1990 |
Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Supplementum. 360: 29-34. PMID 2248064 DOI: 10.1111/J.1600-0447.1990.Tb05321.X |
0.66 |
|
| 1990 |
Hollander E, Neville D, DeCaria C, Mullen L, Schneier FR, Liebowitz MR. On dysmorphophobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics. 31: 468-9. PMID 2247582 DOI: 10.1016/S0033-3182(90)72157-3 |
0.621 |
|
| 1990 |
Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S. Anxiety and depression: discrete diagnostic entities? Journal of Clinical Psychopharmacology. 10: 61S-66S. PMID 2198302 DOI: 10.1097/00004714-199006001-00012 |
0.591 |
|
| 1990 |
Gorman JM, Papp LA, Martinez J, Goetz RR, Hollander E, Liebowitz MR, Jordan F. High-dose carbon dioxide challenge test in anxiety disorder patients. Biological Psychiatry. 28: 743-757. PMID 2124151 DOI: 10.1016/0006-3223(90)90510-9 |
0.457 |
|
| 1990 |
HOLLANDER E, LIEBOWITZ MR, DECARIA C, FAIRBANKS J, FALLON B, KLEIN DF. Treatment of Depersonalization with Serotonin Journal of Clinical Psychopharmacology. 10: 200???202. DOI: 10.1097/00004714-199006000-00008 |
0.674 |
|
| 1989 |
Hollander E, Papp L, Campeas R, DeCaria C, Liebowitz MR. More on self mutilation and obsessive compulsive disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 33: 675. PMID 3058294 DOI: 10.1177/070674378803300728 |
0.609 |
|
| 1989 |
Liebowitz MR, Hollander E. Lactate-induced anxiety. Biological Psychiatry. 25: 669-70. PMID 2923929 DOI: 10.1016/0006-3223(89)90235-7 |
0.52 |
|
| 1989 |
Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer A, Klein DF. Cortisol and sodium lactate-induced panic. Archives of General Psychiatry. 46: 135-40. PMID 2913972 DOI: 10.1001/Archpsyc.1989.01810020037007 |
0.593 |
|
| 1989 |
Goetz RR, Gorman JM, Dillon DJ, Papp LA, Hollander E, Fyer AJ, Liebowitz MR, Klein DF. Do panic disorder patients indiscriminately endorse somatic complaints Psychiatry Research-Neuroimaging. 29: 207-213. PMID 2798599 DOI: 10.1016/0165-1781(89)90035-8 |
0.403 |
|
| 1989 |
Hollander E, Fairbanks J, Decaria C, Liebowitz MR. Pharmacological dissection of panic and depersonalization. The American Journal of Psychiatry. 146: 402. PMID 2784040 DOI: 10.1176/Ajp.146.3.402 |
0.55 |
|
| 1989 |
Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA, Klein DF. Prolactin and sodium lactate-induced panic. Psychiatry Research. 28: 181-91. PMID 2748770 DOI: 10.1016/0165-1781(89)90046-2 |
0.572 |
|
| 1989 |
Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. The American Journal of Psychiatry. 146: 768-70. PMID 2658627 DOI: 10.1176/Ajp.146.6.768 |
0.65 |
|
| 1989 |
Papp LA, Goetz R, Cole R, Klein DF, Jordan F, Liebowitz MR, Fyer AJ, Hollander E, Gorman JM. Hypersensitivity to carbon dioxide in panic disorder. The American Journal of Psychiatry. 146: 779-81. PMID 2499198 DOI: 10.1176/AJP.146.6.779 |
0.468 |
|
| 1989 |
Hollander E, De Caria C, Liebowitz MR. Biological Aspects of Obsessive Compulsive Disorder Psychiatric Annals. 19: 80-87. DOI: 10.3928/0048-5713-19890201-08 |
0.66 |
|
| 1989 |
HOLLANDER E, FAIRBANKS J, DECARIA C, LIEBOWITZ MR. Dr. Hollander and Associates Reply American Journal of Psychiatry. 146: 1361-1361. DOI: 10.1176/Ajp.146.10.1361 |
0.436 |
|
| 1989 |
LIEBOWITZ MR, HOLLANDER E, SCHNEIER F, CAMPEAS R, HATTERER J, PAPP L, FAIRBANKS J, SANDBERG D, DAVIES S, STEIN M. BRIEF REPORTS Journal of Clinical Psychopharmacology. 9: 423???427. DOI: 10.1097/00004714-198912000-00007 |
0.605 |
|
| 1989 |
Hollander E, DeCaria C, Fay M, Liebowitz MR. Repeat M-CPP challenge during fluoxetine treatment in obsessive-compulsive disorder: Behavioral and neuroendocrine responses Biological Psychiatry. 25: A8. DOI: 10.1016/0006-3223(89)91501-1 |
0.618 |
|
| 1989 |
Hollander E, DeCaria C, Cooper T, Liebowitz MR. Neuroendocrine sensitivity in obsessive-compulsive disorder Biological Psychiatry. 25: A5. DOI: 10.1016/0006-3223(89)91496-0 |
0.651 |
|
| 1988 |
Liebowitz MR, Campeas R, Levin A, Sandberg D, Hollander E, Papp L. Pharmacotherapy of social phobia. A condition distinct from panic attacks. Psychosomatics. 28: 305-8. PMID 3324159 DOI: 10.1016/S0033-3182(87)72520-1 |
0.491 |
|
| 1988 |
Hollander E, Liebowitz MR. Augmentation of antiobsessional treatment with fenfluramine. The American Journal of Psychiatry. 145: 1314-5. PMID 3138920 DOI: 10.1176/Ajp.145.10.1314A |
0.48 |
|
| 1988 |
Liebowitz MR, Fyer AJ, Gorman JM, Campeas RB, Sandberg DP, Hollander E, Papp LA, Klein DF. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. Journal of Psychiatric Research. 7-31. PMID 3050060 DOI: 10.1016/0022-3956(88)90067-2 |
0.645 |
|
| 1988 |
Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. The American Journal of Psychiatry. 145: 1015-7. PMID 2839998 DOI: 10.1176/Ajp.145.8.1015 |
0.669 |
|
| 1988 |
HOLLANDER E, FAY M, LIEBOWITZ MR. Clonidine and Clomipramine in Obsessive-Compulsive Disorder American Journal of Psychiatry. 145: 388-a-389. DOI: 10.1176/Ajp.145.3.388-A |
0.664 |
|
| 1988 |
FYER AJ, LIEBOWITZ MR, GORMAN JM, CAMPEAS R, LEVIN A, SANDBERG D, FYER M, HOLLANDER E, PAPP L, GOETZ D, KLEIN DF. Effects of Clonidine on Alprazolam Discontinuation in Panic Patients Journal of Clinical Psychopharmacology. 8: 270???274. DOI: 10.1097/00004714-198808000-00006 |
0.55 |
|
| 1988 |
Hollander E. Neuropharmacology and neuropsychiatry of obsessive-compulsive disorder Journal of Psychiatric Research. 22: 317-318. DOI: 10.1016/0022-3956(88)90055-6 |
0.517 |
|
| 1987 |
Liebowitz MR, Campeas R, Hollander E. MAOIs: impact on social behavior. Psychiatry Research. 22: 89-90. PMID 3659222 DOI: 10.1016/0165-1781(87)90054-0 |
0.477 |
|
| Show low-probability matches. |